Abciximab in Wake-up Stroke

Summary

The purpose of the prospective, randomized, double blind, placebo-controlled multicenter pilot study is to evaluate the effectiveness of abciximab on rescuing the hypoperfused brain tissue, as assessed by MRI, and the relative safety of abciximab in patients with wake-up stroke.

Timeline

Start

2005-03

Primary completion

—

Completion

2005-05

Outcome

Outcome not reported

Stopped: “Higher hemorrhage rates of Abciximab in ABESST II trial”

Drugs

Indications